Portfolio Holdings Detail for ISIN IE00BMX0DF60
Stock Name / Fund iShares US Medical Devices UCITS ETF
Issuer Blackrock
Entity holding fund iShares V Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300QETNU1W5JY7Z94
ETF Ticker UMDV.AS(USD) CXE
ETF Ticker UMDV(USD) Euronext Amsterdam

Holdings detail for PRCT

Stock Name	Procept Biorobotics Corp
Ticker	PRCT(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US74276L1052

Show aggregate PRCT holdings

News associated with PRCT

PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Given Average Rating of “Moderate Buy” by Analysts: PROCEPT BioRobotics Corporation (NASDAQ:PRCT – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the nine ratings firms that are covering the firm, MarketBeat.com reports. One analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 12 month price objective […] - 2025-09-15 05:40:51
PROCEPT BioRobotics (NASDAQ:PRCT) Shares Gap Up on Analyst Upgrade: PROCEPT BioRobotics Corporation (NASDAQ:PRCT – Get Free Report) shares gapped up prior to trading on Tuesday after Oppenheimer upgraded the stock from a market perform rating to an outperform rating. The stock had previously closed at $40.17, but opened at $41.89. Oppenheimer now has a $60.00 price target on the stock. PROCEPT BioRobotics shares last […] - 2025-09-04 02:20:47
Brokerages Set PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Price Target at $74.88: Shares of PROCEPT BioRobotics Corporation (NASDAQ:PRCT – Get Free Report) have been given an average rating of “Moderate Buy” by the nine ratings firms that are covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average […] - 2025-08-19 02:16:54
Deutsche Bank AG Cuts Stock Position in PROCEPT BioRobotics Corporation (NASDAQ:PRCT): Deutsche Bank AG cut its holdings in shares of PROCEPT BioRobotics Corporation (NASDAQ:PRCT – Free Report) by 36.0% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 92,886 shares of the company’s stock after selling 52,356 shares during the period. Deutsche Bank […] - 2025-08-17 05:14:59
Financial Comparison: PROCEPT BioRobotics (NASDAQ:PRCT) & Helius Medical Technologies (NASDAQ:HSDT): Helius Medical Technologies (NASDAQ:HSDT – Get Free Report) and PROCEPT BioRobotics (NASDAQ:PRCT – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, earnings, risk, institutional ownership and valuation. Institutional & Insider Ownership 18.6% of Helius […] - 2025-08-05 04:50:59
IFP Advisors Inc Purchases 2,591 Shares of PROCEPT BioRobotics Corporation (NASDAQ:PRCT): IFP Advisors Inc lifted its stake in PROCEPT BioRobotics Corporation (NASDAQ:PRCT – Free Report) by 358.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,313 shares of the company’s stock after purchasing an additional 2,591 shares during the period. […] - 2025-07-29 04:40:49
Allianz Asset Management GmbH Acquires 837 Shares of PROCEPT BioRobotics Corporation (NASDAQ:PRCT): Allianz Asset Management GmbH boosted its holdings in shares of PROCEPT BioRobotics Corporation (NASDAQ:PRCT – Free Report) by 0.8% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 108,951 shares of the company’s stock after acquiring an additional 837 shares […] - 2025-07-28 04:36:52
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Shares Acquired by Victory Capital Management Inc.: Victory Capital Management Inc. boosted its holdings in PROCEPT BioRobotics Corporation (NASDAQ:PRCT – Free Report) by 13.6% during the first quarter, Holdings Channel reports. The institutional investor owned 173,841 shares of the company’s stock after buying an additional 20,835 shares during the period. Victory Capital Management Inc.’s holdings in PROCEPT BioRobotics were worth $10,128,000 at […] - 2025-07-25 05:14:52
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Receives Average Rating of “Moderate Buy” from Analysts: Shares of PROCEPT BioRobotics Corporation (NASDAQ:PRCT – Get Free Report) have received a consensus rating of “Moderate Buy” from the nine brokerages that are covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average twelve-month price […] - 2025-07-22 07:14:54
Bank of New York Mellon Corp Sells 70,667 Shares of PROCEPT BioRobotics Corporation (NASDAQ:PRCT): Bank of New York Mellon Corp reduced its holdings in shares of PROCEPT BioRobotics Corporation (NASDAQ:PRCT – Free Report) by 28.6% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 176,678 shares of the company’s stock after selling 70,667 shares during the period. Bank of New York Mellon Corp’s holdings in PROCEPT BioRobotics […] - 2025-07-22 06:08:43
Arizona State Retirement System Grows Stock Holdings in PROCEPT BioRobotics Corporation (NASDAQ:PRCT): Arizona State Retirement System boosted its stake in shares of PROCEPT BioRobotics Corporation (NASDAQ:PRCT – Free Report) by 3.2% during the first quarter, Holdings Channel reports. The firm owned 14,737 shares of the company’s stock after purchasing an additional 452 shares during the quarter. Arizona State Retirement System’s holdings in PROCEPT BioRobotics were worth $859,000 […] - 2025-07-21 05:04:48
PROCEPT BioRobotics (NASDAQ:PRCT) Stock Price Down 4.7% Following Analyst Downgrade: Shares of PROCEPT BioRobotics Corporation (NASDAQ:PRCT – Get Free Report) were down 4.7% during trading on Tuesday after Morgan Stanley lowered their price target on the stock from $71.00 to $68.00. Morgan Stanley currently has an overweight rating on the stock. PROCEPT BioRobotics traded as low as $54.65 and last traded at $55.45. Approximately 352,268 […] - 2025-07-16 02:26:59
Brokerages Set PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Price Target at $90.00: Shares of PROCEPT BioRobotics Corporation (NASDAQ:PRCT – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the seven analysts that are presently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and six have issued a buy rating on the company. The average twelve-month price […] - 2025-07-02 05:56:52
Diversified Trust Co Grows Stake in PROCEPT BioRobotics Corporation (NASDAQ:PRCT): Diversified Trust Co increased its holdings in shares of PROCEPT BioRobotics Corporation (NASDAQ:PRCT – Free Report) by 54.6% in the 1st quarter, Holdings Channel.com reports. The firm owned 7,187 shares of the company’s stock after acquiring an additional 2,538 shares during the quarter. Diversified Trust Co’s holdings in PROCEPT BioRobotics were worth $419,000 as of […] - 2025-07-01 05:27:01
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Shares Purchased by Avior Wealth Management LLC: Avior Wealth Management LLC lifted its stake in PROCEPT BioRobotics Corporation (NASDAQ:PRCT – Free Report) by 138.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 4,918 shares of the company’s stock after purchasing an additional 2,856 shares during the quarter. Avior Wealth […] - 2025-06-23 05:51:03
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Shares Bought by Blue Trust Inc.: Blue Trust Inc. increased its stake in PROCEPT BioRobotics Corporation (NASDAQ:PRCT – Free Report) by 28.8% during the first quarter, HoldingsChannel.com reports. The fund owned 4,996 shares of the company’s stock after buying an additional 1,118 shares during the period. Blue Trust Inc.’s holdings in PROCEPT BioRobotics were worth $291,000 at the end of the […] - 2025-06-23 05:00:55
PROCEPT BioRobotics Co. (NASDAQ:PRCT) Receives $90.00 Average Target Price from Analysts: Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT – Get Free Report) have received an average recommendation of “Moderate Buy” from the seven research firms that are presently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The […] - 2025-06-05 02:16:50
Wall Street Zen Upgrades PROCEPT BioRobotics (NASDAQ:PRCT) to “Hold”: PROCEPT BioRobotics (NASDAQ:PRCT – Get Free Report) was upgraded by research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a note issued to investors on Saturday. Several other research analysts also recently commented on PRCT. Bank of America reduced their price target on shares of PROCEPT BioRobotics from $104.00 […] - 2025-05-26 02:38:53
Bank of America Corp DE Has $50.20 Million Stock Holdings in PROCEPT BioRobotics Co. (NASDAQ:PRCT): Bank of America Corp DE boosted its position in shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT – Free Report) by 6.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 623,408 shares of the company’s stock after purchasing an additional 36,944 shares during the quarter. Bank […] - 2025-05-14 06:16:48
PROCEPT BioRobotics Co. (NASDAQ:PRCT) Shares Sold by Schonfeld Strategic Advisors LLC: Schonfeld Strategic Advisors LLC lowered its holdings in shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT – Free Report) by 38.2% in the fourth quarter, HoldingsChannel.com reports. The fund owned 3,300 shares of the company’s stock after selling 2,036 shares during the quarter. Schonfeld Strategic Advisors LLC’s holdings in PROCEPT BioRobotics were worth $266,000 at the end […] - 2025-05-13 05:42:52
PROCEPT BioRobotics (NASDAQ:PRCT) Sees Large Volume Increase After Better-Than-Expected Earnings: PROCEPT BioRobotics Co. (NASDAQ:PRCT – Get Free Report) saw unusually-high trading volume on Thursday following a stronger than expected earnings report. Approximately 797,959 shares traded hands during trading, an increase of 1% from the previous session’s volume of 793,946 shares.The stock last traded at $51.90 and had previously closed at $55.70. The company reported ($0.45) […] - 2025-04-25 02:54:47
PROCEPT BioRobotics Co. (NASDAQ:PRCT) Given Average Recommendation of “Moderate Buy” by Brokerages: PROCEPT BioRobotics Co. (NASDAQ:PRCT – Get Free Report) has been given a consensus rating of “Moderate Buy” by the seven research firms that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold rating and six have given a buy rating to the company. The average 12 month […] - 2025-04-18 05:08:54
PROCEPT BioRobotics Co. (NASDAQ:PRCT) Shares Purchased by Invesco Ltd.: Invesco Ltd. raised its stake in PROCEPT BioRobotics Co. (NASDAQ:PRCT – Free Report) by 86.2% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 499,949 shares of the company’s stock after buying an additional 231,470 shares during the quarter. Invesco Ltd.’s holdings in PROCEPT BioRobotics were worth $40,256,000 […] - 2025-04-17 05:46:55
Orion Portfolio Solutions LLC Takes $530,000 Position in PROCEPT BioRobotics Co. (NASDAQ:PRCT): Orion Portfolio Solutions LLC bought a new position in shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 6,585 shares of the company’s stock, valued at approximately $530,000. A number of other institutional investors have […] - 2025-04-08 05:34:58
Pictet Asset Management Holding SA Has $751,000 Holdings in PROCEPT BioRobotics Co. (NASDAQ:PRCT): Pictet Asset Management Holding SA boosted its holdings in PROCEPT BioRobotics Co. (NASDAQ:PRCT – Free Report) by 27.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 9,326 shares of the company’s stock after purchasing an additional 1,991 shares during the quarter. Pictet Asset […] - 2025-04-08 04:57:04
KLP Kapitalforvaltning AS Makes New Investment in PROCEPT BioRobotics Co. (NASDAQ:PRCT): KLP Kapitalforvaltning AS acquired a new position in shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 9,700 shares of the company’s stock, valued at approximately $781,000. Other institutional investors also recently modified […] - 2025-04-01 05:50:57
Teacher Retirement System of Texas Takes $768,000 Position in PROCEPT BioRobotics Co. (NASDAQ:PRCT): Teacher Retirement System of Texas bought a new position in shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT – Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 9,543 shares of the company’s stock, valued at approximately $768,000. Several other large investors have also […] - 2025-03-31 04:28:57
Zurcher Kantonalbank Zurich Cantonalbank Has $1.13 Million Position in PROCEPT BioRobotics Co. (NASDAQ:PRCT): Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT – Free Report) by 4.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,968 shares of the company’s stock after purchasing an additional 652 shares […] - 2025-03-20 06:16:51
Arizona State Retirement System Boosts Stake in PROCEPT BioRobotics Co. (NASDAQ:PRCT): Arizona State Retirement System increased its stake in shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT – Free Report) by 1.5% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 14,285 shares of the company’s stock after purchasing an additional 218 shares during the period. Arizona State Retirement System’s […] - 2025-03-14 06:10:57
IFP Advisors Inc Makes New Investment in PROCEPT BioRobotics Co. (NASDAQ:PRCT): IFP Advisors Inc purchased a new position in shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 722 shares of the company’s stock, valued at approximately $58,000. Several other hedge funds and other institutional investors also […] - 2025-03-07 06:48:57

iShares US Medical Devices UCITS ETF PRCT holdings

Date	Number of PRCT Shares Held	Base Market Value of PRCT Shares	Local Market Value of PRCT Shares	Change in PRCT Shares Held	Change in PRCT Base Value	Current Price per PRCT Share Held	Previous Price per PRCT Share Held
2025-09-18 (Thursday)	7,352	USD 279,597	USD 279,597	0	USD 5,514	USD 38.0301	USD 37.2801
2025-09-17 (Wednesday)	7,352	USD 274,083	USD 274,083	0	USD -16,836	USD 37.2801	USD 39.57
2025-09-16 (Tuesday)	7,352	USD 290,919	USD 290,919
2025-09-15 (Monday)	7,352	USD 279,376	USD 279,376
2025-09-12 (Friday)	7,352	USD 273,053	USD 273,053
2025-09-11 (Thursday)	7,352	USD 284,081	USD 284,081
2025-09-10 (Wednesday)	7,352	USD 275,700	USD 275,700
2025-09-09 (Tuesday)	7,352	USD 290,551	USD 290,551
2025-09-08 (Monday)	7,352	USD 286,140	USD 286,140

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of PRCT by Blackrock for IE00BMX0DF60

Show aggregate share trades of PRCT

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-06-27 SELL -120 56.910* 67.53 Profit of 8,103 on sale
2025-06-12 BUY 174 61.160* 68.07
2025-06-10 SELL -928 64.230* 68.15 Profit of 63,239 on sale
2025-06-09 SELL -1,102 62.860* 68.19 Profit of 75,141 on sale
2025-05-30 SELL -116 58.000* 68.54 Profit of 7,951 on sale
2025-05-19 BUY 58 59.290* 69.39
2025-05-09 SELL -300 53.120* 70.17 Profit of 21,051 on sale
2025-04-23 SELL -60 55.700* 72.18 Profit of 4,331 on sale
2025-04-17 SELL -59 53.030* 73.01 Profit of 4,308 on sale
2025-04-10 BUY 472 50.730* 74.19
2025-04-04 SELL -118 51.230* 75.29 Profit of 8,884 on sale
2025-04-02 SELL -118 57.740* 75.50 Profit of 8,910 on sale
2025-03-31 SELL -177 58.260* 75.95 Profit of 13,443 on sale
2025-03-19 SELL -58 57.800* 77.70 Profit of 4,507 on sale
2025-02-28 SELL -116 64.340* 81.29 Profit of 9,430 on sale
2025-02-05 BUY 177 73.810* 86.84
2025-02-04 BUY 236 71.590* 87.21
2025-01-29 SELL -59 72.950* 88.80 Profit of 5,239 on sale
2025-01-23 SELL -59 69.640* 90.70 Profit of 5,351 on sale
2025-01-02 BUY 420 83.160* 90.93
2024-12-04 BUY 165 99.450* 90.32
2024-12-03 SELL -55 96.480* 90.09 Profit of 4,955 on sale
2024-12-02 SELL -660 96.110* 89.86 Profit of 59,308 on sale
2024-11-29 SELL -1,100 95.590* 89.63 Profit of 98,594 on sale
2024-11-27 SELL -165 97.290* 88.97 Profit of 14,679 on sale
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-06-27	SELL	-120	56.910*	67.53 Profit of 8,103 on sale
2025-06-12	BUY	174	61.160*	68.07
2025-06-10	SELL	-928	64.230*	68.15 Profit of 63,239 on sale
2025-06-09	SELL	-1,102	62.860*	68.19 Profit of 75,141 on sale
2025-05-30	SELL	-116	58.000*	68.54 Profit of 7,951 on sale
2025-05-19	BUY	58	59.290*	69.39
2025-05-09	SELL	-300	53.120*	70.17 Profit of 21,051 on sale
2025-04-23	SELL	-60	55.700*	72.18 Profit of 4,331 on sale
2025-04-17	SELL	-59	53.030*	73.01 Profit of 4,308 on sale
2025-04-10	BUY	472	50.730*	74.19
2025-04-04	SELL	-118	51.230*	75.29 Profit of 8,884 on sale
2025-04-02	SELL	-118	57.740*	75.50 Profit of 8,910 on sale
2025-03-31	SELL	-177	58.260*	75.95 Profit of 13,443 on sale
2025-03-19	SELL	-58	57.800*	77.70 Profit of 4,507 on sale
2025-02-28	SELL	-116	64.340*	81.29 Profit of 9,430 on sale
2025-02-05	BUY	177	73.810*	86.84
2025-02-04	BUY	236	71.590*	87.21
2025-01-29	SELL	-59	72.950*	88.80 Profit of 5,239 on sale
2025-01-23	SELL	-59	69.640*	90.70 Profit of 5,351 on sale
2025-01-02	BUY	420	83.160*	90.93
2024-12-04	BUY	165	99.450*	90.32
2024-12-03	SELL	-55	96.480*	90.09 Profit of 4,955 on sale
2024-12-02	SELL	-660	96.110*	89.86 Profit of 59,308 on sale
2024-11-29	SELL	-1,100	95.590*	89.63 Profit of 98,594 on sale
2024-11-27	SELL	-165	97.290*	88.97 Profit of 14,679 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of PRCT

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	222,958	2,317	356,138	62.6%
2025-09-18	231,038	17,148	367,057	62.9%
2025-09-17	314,030	49,052	434,852	72.2%
2025-09-16	468,407	313	627,755	74.6%
2025-09-15	267,050	100	420,240	63.5%
2025-09-12	274,646	0	386,919	71.0%
2025-09-11	372,835	0	505,561	73.7%
2025-09-10	611,763	59	832,416	73.5%
2025-09-09	293,810	8,986	367,261	80.0%
2025-09-08	350,408	0	417,875	83.9%
2025-09-05	230,090	0	323,461	71.1%
2025-09-04	209,637	0	287,491	72.9%
2025-09-03	262,601	51	322,457	81.4%
2025-09-02	589,367	80	660,720	89.2%
2025-08-29	202,523	0	252,835	80.1%
2025-08-28	197,637	100	283,786	69.6%
2025-08-27	164,588	0	254,277	64.7%
2025-08-26	306,212	4,219	365,834	83.7%
2025-08-25	336,773	19	418,871	80.4%
2025-08-22	163,592	0	255,793	64.0%
2025-08-21	182,518	0	228,420	79.9%
2025-08-20	184,089	845	250,994	73.3%
2025-08-19	224,686	5,589	286,025	78.6%
2025-08-18	148,041	10,363	198,644	74.5%
2025-08-15	366,687	503	447,423	82.0%
2025-08-14	454,577	0	509,097	89.3%
2025-08-13	279,698	0	374,083	74.8%
2025-08-12	368,746	0	462,069	79.8%
2025-08-11	593,470	8,021	1,064,504	55.8%
2025-08-08	653,355	9,217	1,031,755	63.3%
2025-08-07	1,528,572	101,988	2,044,955	74.7%
2025-08-06	598,531	1,035	702,259	85.2%
2025-08-05	319,694	0	452,028	70.7%
2025-08-04	180,787	1,574	225,456	80.2%
2025-08-01	273,055	2,224	489,866	55.7%
2025-07-31	246,743	2,938	458,025	53.9%
2025-07-30	957,448	3,244	1,093,232	87.6%
2025-07-29	330,335	0	395,668	83.5%
2025-07-28	341,428	7,283	444,477	76.8%
2025-07-25	963,869	11,498	1,621,154	59.5%
2025-07-24	343,375	0	487,128	70.5%
2025-07-23	178,704	0	263,925	67.7%
2025-07-22	242,455	54	292,911	82.8%
2025-07-21	263,809	0	337,390	78.2%
2025-07-18	529,841	40	570,568	92.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares US Medical Devices UCITS ETF
Issuer	Blackrock
Entity holding fund	iShares V Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300QETNU1W5JY7Z94
ETF Ticker	UMDV.AS(USD) CXE
ETF Ticker	UMDV(USD) Euronext Amsterdam